Genome British Columbia (Genome BC) is pleased to welcome Pat Brady in the role of Director, Industry Innovation Programs. This role will be pivotal in advancing genomic tools and technologies through the research continuum to commercialization.
A seasoned professional, Pat has been involved with growing innovative companies, notably in life sciences, for the past 24 years. He also has experience as a venture capitalist, hands-on practice evaluating IP, product development and commercial pathways as well as the market potential of life science technologies.
We are very pleased to be adding significant hands-on experience to our team and believe that Pat will be a strong asset in supporting our mission and the goals set out in the 2015-2020 Strategic Plan.
To learn more about our Industry Innovation Program, click here.